Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Nature Communications|June 13, 2019
Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13dBo Zhang, Yangmiao Ye, Weiwei Ye, et al.
Rheumatology International|December 17, 2009
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patientsZhiming Lin, Jieruo Gu, Peigen He, et al.
International Journal of Rheumatic Diseases|May 28, 2015
A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemiaShaoyong Xu, Xiangyang Liu, Jie Ming, et al.
Bone|July 2, 2019
Aberrant activation of Wnt signaling pathway altered osteocyte mineralizationYinghong Zhou, Jinying Lin, Jin Shao, et al.
Cancer|December 21, 2022
Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in ChinaYan Gao, Yizhen Liu, Yafei Wang, et al.
Frontiers in Medicine|February 19, 2021
YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical TrialWeiping Liu, Yufu Li, Quanshun Wang, et al.
Arthritis Care & Research|September 12, 2013
Societal costs of rheumatoid arthritis in China: a hospital-based cross-sectional studyChuanhui Xu, Xiuru Wang, Rong Mu, et al.
Rheumatology and Therapy|November 22, 2021
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III StudyYanying Liu, Shengyun Liu, Lin Liu, et al.
BMC Medicine|December 8, 2025
Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trialYue Cheng, Honghu Tang, Yufeng Qing, et al.
Rheumatology (Oxford, England)|March 25, 2015
The impact of rheumatoid arthritis on work capacity in Chinese patients: a cross-sectional studyXiaoying Zhang, Rong Mu, Xiuru Wang, et al.
Pageof 5